Kiadis Pharma's Extraordinary General Meeting of Shareholders Approves CytoSen Acquisition
29 mai 2019 06h05 HE
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, May 29, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces...
Kiadis Submits Response to the European Medicines Agency's Day 180 Second List of Outstanding Issues
22 mai 2019 14h11 HE
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, May 22, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announced...
Be The Match BioTherapies® and Kiadis Pharma Announce Strategic Collaboration to Accelerate Patient Access to Haploidentical Stem Cell Therapies
22 mai 2019 12h00 HE
|
Kiadis Pharma Netherlands B.V.
Collaboration will support Phase III clinical trial of cell therapy product ATIR101(TM) for blood cancers MINNEAPOLIS & AMSTERDAM, May 22, 2019 - Be The Match BioTherapies®, an organization...
Kiadis Pharma Notice of Annual General Meeting of Shareholders
13 mai 2019 12h48 HE
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, 13 May 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a...
Kiadis Pharma announces annual results for the year ended December 31, 2018
30 avr. 2019 11h45 HE
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, 30 April 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a...
Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders
17 avr. 2019 08h55 HE
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, April 17, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels:...
Kiadis to Acquire CytoSen Therapeutics, Inc.
17 avr. 2019 01h00 HE
|
Kiadis Pharma Netherlands B.V.
Kiadis to Acquire CytoSen Therapeutics, Inc. Transaction creates leader in cell-based cancer immunotherapy, with complementary T-cell and NK-cell...
Kiadis Pharma to present at upcoming investor conferences in April 2019
09 avr. 2019 11h45 HE
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to present at upcoming investor conferences in April 2019 Amsterdam, The Netherlands, April 9, 2019 - Kiadis Pharma N.V. ("Kiadis...
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders
29 mars 2019 13h30 HE
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders Amsterdam, The Netherlands, March 29, 2019 -...
Kiadis Pharma Strengthens Management Team
05 mars 2019 11h45 HE
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma Strengthens Management Team Dirk de Naeyer appointed Chief Operations Officer and Martine Nolan as Head of Quality Assurance,...